HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Helmut R Maecke Selected Research

3-Tyr-octreotide

5/2009[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial.
7/2008Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
8/2005Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC.
1/2005Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Helmut R Maecke Research Topics

Disease

46Neoplasms (Cancer)
08/2015 - 02/2002
12Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2014 - 05/2002
5Prostatic Neoplasms (Prostate Cancer)
08/2015 - 10/2003
3Glioblastoma (Glioblastoma Multiforme)
12/2011 - 06/2006
3Neoplasm Metastasis (Metastasis)
01/2008 - 10/2003
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2011 - 12/2011
2Glioma (Gliomas)
12/2011 - 06/2006
2Carcinoma (Carcinomatosis)
02/2011 - 10/2003
1Meningioma (Meningiomas)
02/2015
1Gastrinoma
01/2015
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2014
1Necrosis
11/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2013
1Brain Neoplasms (Brain Tumor)
12/2011
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2011
1Breast Neoplasms (Breast Cancer)
12/2011
1Ovarian Neoplasms (Ovarian Cancer)
12/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2009
1Thyroid Neoplasms (Thyroid Cancer)
05/2009
1Lung Neoplasms (Lung Cancer)
09/2004
1Solitary Pulmonary Nodule
07/2004
1Carcinoid Tumor (Carcinoid)
10/2003
1Melanoma (Melanoma, Malignant)
10/2003
1Leiomyosarcoma
10/2003

Drug/Important Bio-Agent (IBA)

19Somatostatin Receptors (Somatostatin Receptor)IBA
02/2015 - 02/2002
16Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2015 - 02/2002
13PeptidesIBA
11/2014 - 01/2004
12BombesinIBA
08/2015 - 09/2004
11Bombesin Receptors (Bombesin Receptor)IBA
08/2015 - 09/2004
9Peptide Receptors (Peptide Receptor)IBA
06/2015 - 04/2007
6Octreotide (Sandostatin)FDA LinkGeneric
10/2010 - 01/2005
43-Tyr-octreotideIBA
05/2009 - 01/2005
4yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
05/2009 - 01/2005
3Cholecystokinin B ReceptorIBA
06/2015 - 04/2011
3DOTA-Tyr(3)- 90Y-octreotideIBA
02/2015 - 08/2005
3Arginine (L-Arginine)FDA Link
11/2014 - 08/2011
3Aspartic Acid (Aspartate)FDA Link
11/2014 - 08/2011
3Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2014 - 08/2011
3LigandsIBA
11/2013 - 04/2008
3GastrinsIBA
12/2011 - 11/2008
3Radioisotopes (Radionuclides)IBA
12/2011 - 12/2005
3(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)IBA
08/2005 - 02/2002
2DOTA(0)-Tyr(3)- 177Lu-octreotideIBA
02/2015 - 08/2005
2IntegrinsIBA
11/2014 - 12/2011
2Substance PIBA
12/2011 - 06/2006
2GTP-Binding Proteins (G-Protein)IBA
12/2011 - 08/2009
2medullary Thyroid cancerIBA
12/2011 - 04/2011
2DOTA-PEG(4)-bombesin (7-14)IBA
02/2011 - 08/2007
2Pentetic Acid (DTPA)FDA LinkGeneric
01/2005 - 09/2004
1alanyltyrosineIBA
08/2015
1minigastrinIBA
06/2015
1Angiogenesis InhibitorsIBA
11/2014
1bevacizumabFDA Link
11/2014
1Serine Proteases (Serine Protease)IBA
06/2014
1IncretinsIBA
06/2014
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
06/2014
1GelatinIBA
06/2014
1gastric inhibitory polypeptide receptorIBA
06/2014
1glycylhistidineIBA
01/2014
1n-hexadecaneIBA
01/2014
1rituximab (Mabthera)FDA Link
07/2013
1pemetrexed (MTA)FDA Link
05/2012
1A-factor (Streptomyces)IBA
05/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
05/2012
1somatostatin receptor 2IBA
03/2012
1Glutamic Acid (Glutamate)FDA Link
04/2011
1pasireotideIBA
10/2010
1AntibodiesIBA
09/2009
1IodineIBA
05/2009
1ThyroglobulinFDA Link
05/2009
1YttriumIBA
05/2009
1Cholecystokinin (Pancreozymin)IBA
11/2008
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2008
1Neuropeptide YIBA
11/2008
1arginyl-glycyl-aspartic acidIBA
11/2008
16-hydrazinopyridine-3-carboxylic acidIBA
07/2008
1cysteinyltyrosineIBA
08/2005
1Immunoconjugates (Immunoconjugate)IBA
07/2005
1glycyl-glycyl-glycine (triglycine)IBA
07/2005
1pentetreotide (OctreoScan)FDA Link
01/2005
1Tyr(3)- octreotateIBA
01/2005
1EDDA (NiEDDA)IBA
07/2004
1Adrenocorticotropic Hormone (ACTH)FDA Link
10/2003

Therapy/Procedure

13Radiotherapy
01/2014 - 02/2002
9Heterologous Transplantation (Xenotransplantation)
01/2015 - 07/2005
2Aftercare (After-Treatment)
02/2015 - 08/2005
2Radioimmunotherapy
07/2013 - 07/2005
1Catheters
12/2011
1Intravenous Injections
06/2009
1Brachytherapy
06/2006
1Injections
09/2004